BioCatalystWatch
INDVWorkspace / INDV / OverviewCompany library
Indivior Pharmaceuticals, Inc. logo

Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. (INDV)

Website

Featured programme · INDV-1000

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

INDV-1000

GABA-B receptor

PreINDP1P2P3FilingApproved

Approved / commercial

History / paused

Orexin-1 receptor (OX1R)

PreINDP1P2P3FilingApproved

μ-opioid receptor

Approved

PreINDP1P2P3FilingApproved

Opioid receptors

Approved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

INDV PR & News

PR & News

INDV SEC archive